For individuals with DEEs related to GOF variants in SCN2A and SCN8A, sodium channel blockers may be beneficial in the management of epilepsy; in contrast, with LOF variants in SCN2A and SCN8A, sodium channel blockers may worsen the epilepsy phenotype [126,127]. This evidence concerns the gene SCN8A and epilepsy.